Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPID | Q08752 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5556642 | 0.89 | PPID (0.48) | PPIDALOX5ABCB1HSD11B1SMN1; SMN2 | |
| SCHEMBL6513757 | 0.87 | LMNA (0.41) | ALOX5SMN1; SMN2MAPTTDP1SLC13A5 | |
| SCHEMBL6522438 | 0.83 | SLC13A5 (0.40) | TDP1L3MBTL1SLC13A5 | |
| SCHEMBL6514741 | 0.80 | GAA (0.40) | HSD11B1SMN1; SMN2TSHR | |
| SCHEMBL6523907 | 0.78 | ALDH1A1 (0.51) | SMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL6518125 | 0.78 | TDP1 (0.45) | ALOX5SMN1; SMN2TDP1L3MBTL1TSHR | |
| SCHEMBL5556625 | 0.78 | PPID (0.43) | PPIDALOX5ABCB1HSD11B1SMN1; SMN2 | |
| SCHEMBL18065664 | 0.78 | ALDH1A1 (0.49) | PPIDALOX5SMN1; SMN2MAPTTDP1 | |
| SCHEMBL6523574 | 0.78 | ALDH1A1 (0.42) | SMN1; SMN2MAPTTDP1L3MBTL1 | |
| SCHEMBL6514660 | 0.77 | GAA (0.38) | HSD11B1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | PPID 4488/4885ALOX5 1349/4885ABCB1 2481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.